Key statistics dashboard for Aditxt, Inc. (ADTX). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques. The company's developments include AditxtScore, a platform designed to empower individuals by providing insights into their immune profiles for better management and informed awareness of immune system attacks or dysfunctions.
Stock Data
| Price | $0.01 |
| Market Cap | $5M |
| Exchange | OTC |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.00 |
| Price / Book | -0.00 |
| P/S | 355.03 |
| P/FCF | -0.27 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 19.89% |
| EBIT Margin | -355342.39% |
| EBITDA Margin | -353584.32% |
| Operating Margin | -127821.37% |
| Net Margin | -362385.72% |
Financial Health
| Current Ratio | 0.06 |
| Quick Ratio | 0.05 |
| Cash Ratio | 0.02 |
| Debt / Equity | -0.13 |
| Debt / Assets | 30.44% |
| Interest Coverage | -8.80 |
Per-Share Data
| Revenue per share | 0.71 |
| Book Value per share | -1743.55 |
| Cash per share | 13.33 |
| FCF per share | -920.88 |
| Tangible Book Value per share | -1770.28 |
| Dividend per share | 0.00 |
Related companies: AIMD · ANL · APLM · ATHA · BLRX · CTXR · GOVX
Explore sector: Healthcare · Biotechnology
More sections of ADTX: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks